Neuro-protective effects of cerium and yttrium oxide nanoparticles on high glucose-induced oxidative stress and apoptosis in undifferentiated PC12 cells

Neurological Research

Volumn 37, Issue 7, 2015, Pages 624-632

  Ghaznavi, Habib ^a   Najafi, Rezvan ^b   Mehrzadi, Saeed ^a   Hosseini, Asieh ^c   Tekyemaroof, Neda ^c   Shakeri Zadeh, Ali ^d   Rezayat, Mehdi ^d   Sharifi, Ali M ^a,b,c,e  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Cerium and yttrium oxide nanoparticles; High glucose; Neurotoxicity; Oxidative stress

Indexed keywords

CASPASE 3; CERIUM OXIDE NANOPARTICLE; GLUCOSE; NANOPARTICLE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; THIOL; UNCLASSIFIED DRUG; YTTRIUM OXIDE NANOPARTICLE; BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; CERIC OXIDE; CERIUM; METAL NANOPARTICLE; NEUROPROTECTIVE AGENT; SCAVENGER; THIOL DERIVATIVE; YTTRIA; YTTRIUM;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; LIPID PEROXIDATION; MTT ASSAY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PC12 CELL LINE; QUANTITATIVE ANALYSIS; SURVIVAL; WESTERN BLOTTING; X RAY PHOTOELECTRON SPECTROSCOPY; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; RAT;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL SURVIVAL; CERIUM; FREE RADICAL SCAVENGERS; GLUCOSE; LIPID PEROXIDATION; METAL NANOPARTICLES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; YTTRIUM;

EID: 84930468564     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132815Y.0000000037     Document Type: Article

References (56)

1. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys. 2005;43: 289–330.
2. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.
3. Kasznicki J, Kosmalski M, Sliwinska A, Mrowicka M, Stanczyk M, Majsterek I, et al. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Rep. 2012;39(9):8669–78.
4. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25:612–28.
5. Catherwood MA, Powell LA, Anderson P, McMaster D, Sharpe PC, Trimble ER. Glucose-induced oxidative stress in mesangial cells. Kidney Int. 2002;61:599–608.
6. Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci. 2002;959:368–83.
7. Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res. 2007;73:549–59.
8. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, et al. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 2002; 16:1738–48.
9. Liu G, Men P, Harris PL, Rolston RK, Perry G, Smith MA. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci Lett. 2006;406:189–93.
10. Kabanov A, Gendelman H. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog Polym Sci. 2007;32:1054–82.
11. Gilmore JL, Yi X, Quan L, Kabanov AV. Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol. 2008;3: 83–94.
12. Sharifi AM, Mousavi SH, Farhadi M, Larijani B. Study of high glucose-induced apoptosis in PC12 cells: role of bax protein. J Pharmacol Sci. 2007;104:258–62.
13. Beche E, Charvin P, Perarnau D, Abanades S, Flamant G. Ce 3dXPS investigation of Cerium oxides and mixed Cerium Oxide (Cex T1yO2). Surf Interface Anal. 2008;40:264–7.
14. Brownlee M. The pathobiology of diabetic complications. Diabetes. 2005;54:1615–25.
15. Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002; 288:2579–88.
16. Merzouk S, Hichami A, Madani S, Merzouk H, Berrouiguet AY, Prost J, et al. Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen Physiol Biophys. 2003;22:15–28.
17. Sharifi AM, Eslami H, Larijani B, Davoodi J. Involvement of caspase-8,-9, and-3 in high glucose-induced apoptosis in PC12 cells. Neurosci Lett. 2009;459:47–51.
18. Koshimura K, Tanaka J, Murakami Y, Kato Y. Involvement of nitric oxide in glucose toxicity on differentiated PC12 cells: prevention of glucose toxicity by tetrahydrobiopterin, a cofactor for nitric oxide synthase. Neurosci Res. 2002;43:31–8.
19. Lelkes E, Unsworth BR, Lelkes PI. Reactive oxygen species, apoptosis and altered NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic neuropathy. Neurotox Res. 2001;3:189–203.
20. Mousavi S, Tayarani N, Parsaee H. Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in PC12 cells. Cell Mol Neurobiol. 2010;30:185–91.
21. Singh N, Cohen CA, Rzigalinski BA. Treatment of neurodegenerative disorders with radical nanomedicine. Ann N Y Acad Sci. 2007;1122:219–30.
22. Klochkov VK, Grigorova AV, Sedyh OO, Malyukin YV. The influence of agglomeration of nanoparticles on their superoxide dismutase-mimetic activity. Colloids Surf A. 2012;409:176–82.
23. Sun J, Wang S, Zhao D, Hun FH, Weng L, Liu H. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells. Cell Biol Toxicol. 2011;27(5):333–42.
24. Heckert EG, Karakoti AS, Seal S, Self WT. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials. 2008;29:2705–9.
25. Pourkhalili N, Hosseini A, Nili-Ahmadabadi A, Hassani S, Pakzad M, Baeeri M, et al. Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats. World J Diabetes. 2011;2:204.
26. Jessica E. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun. 2010;46:2736–8.
27. Clark A, Zhu A, Sun K, Petty HR. Cerium oxide and platinum nanoparticles protect cells from oxidant-mediated apoptosis. J Nanopart Res. 2011;13:5547–55.
28. 3+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles. ACS Nano. 2011;5: 4537–49.
29. Estevez AY, Pritchard S, Harper K, Aston JW, Lynch A, Lucky JJ, et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med. 2011;51:1155–63.
30. Higdon BP. Cerium oxide nanoparticles as antioxidants. da Vinci’s Notebook. 2012;4:1–2.
31. Hirst SM, Karakoti A, Singh S, Self W, Tyler R, Seal S, et al. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol. 2013;28:107–18.
32. Estevez A, Erlichman J. Cerium oxide nanoparticles for the treatment of neurological oxidative stress diseases. Brain. 2011;28:30.
33. Ciofani G, Genchi GG, Liakos I, Cappello V, Gemmi M, Athanassiou A, et al. Effects of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion. Pharm Res. 2013;30:2133–45.
34. Ciofani G, Genchi GG, Mazzolai B, Mattoli V. Transcriptional profile of genes involved in oxidative stress and antioxidant defense in PC12 cells following treatment with cerium oxide nanoparticles. Biochim Biophys Acta. 2014;1840:495–506.
35. Schubert D, Dargusch R, Raitano J, Chan SW. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun. 2006;342:86–91.
36. Tarnuzzer RW, Colon J, Patil S, Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 2005;5:2573–7.
37. Amin KA, Hassan MS, Awad el- ST, Hashem KS. The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline. Int J Nanomed. 2011;6:143.
38. Mohammad G, Mishra VK, Pandey H. Antioxidant properties of some nanoparticle may enhance wound healing in T2DM patient. Dig J Nanomater Biostruct. 2008;3:159–62.
39. Hosseini A, Abdollahi M. Through a mechanism-based approach, nanoparticles of cerium and yttrium may improve the outcome of pancreatic islet isolation. J Med Hypotheses Ideas. 2012;6(1):4–6.
40. Hosseini A, Baeeri M, Rahimifard M, Navaei-Nigjeh M, Mohammadirad A, Pourkhalili N, et al. Antiapoptotic effects of cerium oxide and yttrium oxide nanoparticles in isolated rat pancreatic islets. Hum Exp Toxicol. 2013;32:544–53.
41. Andreescu ES, Leiter JC, Erlichman JS. Method of neuroprotection from oxidant injury using metal oxide nanoparticles, US Patent Application 2010/0098768, 2009.
42. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001;281:E924–30.
43. Sheu ML, Ho FM, Yang RS, Chao KF, Lin WW Lin-Shiau, et al., High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol. 2005;25:539–45.
44. Franco R, Cidlowski J. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ. 2009;16:1303–14.
45. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem. 2005;16:705–13.
46. Piro S, Anello M, Di Pietro C, Lizzio MN, Patanè G, Rabuazzo AM, et al. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism. 2002;51:1340–7.
47. Hasnan J, Yusof MI, Damitri TD, Faridah AR, Adenan AS, Norbaini TH. Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J. 2010;51:50–5.
48. Simon H-U, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5:415–8.
49. Meng X, Li ZM, Zhou YJ, Cao YL, Zhang J. Effect of the antioxidant a-lipoic acid on apoptosis in human umbilical vein endothelial cells induced by high glucose. Clin Exp Med. 2008;8:43–9.
50. Milei J, Forcada P, Fraga CG, Grana DR, Iannelli G, Chiariello M, et al. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/ reperfusion. Cardiovasc Res. 2007;73:710–9.
51. Srivastava S, Chandrasekar B, Bhatnagar A, Prabhu SD. Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase. Am J Physiol Heart Circ Physiol. 2002;283:H2612–9.
52. Mattson MP. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 1998;21:53–7.
53. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and b-cell damage in rat pancreas. Pharmacol Res. 2005;51:117–23.
54. El-Shafey AF, Armstrong AE, Terrill JR, Grounds MD, Arthur PG. Screening for increased protein thiol oxidation in oxidatively stressed muscle tissue. Free Radic Res. 2011;17:1–9.
55. Costa CM, Santos RCC, Lima ES. A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab. 2006;42:345–50.
56. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. 2008;295:C849–68.